专利名称：METHOD AND PHARMACEUTICAL
COMPOSITION FOR INHIBITINGPI3K/AKT/MTOR SIGNALING PATHWAY
发明人：Lei Duan,Victor Levenson,Guoguang Ying申请号：US14431441申请日：20130929
公开号：US20150328197A1公开日：20151119
摘要：The present invention relates to a pharmaceutical composition of PRCPantagonist, PREP antagonist, or PRCP-PREP dual antagonist. The present invention alsorelates to a pharmaceutical composition jointly using PRCP antagonist and mTORantagonist, or jointly using PREP antagonist and mTOR antagonist, or jointly using PRCP-PREP dual antagonist and mTOR antagonist. In addition, the present invention alsorelates to a method for utilizing the pharmaceutical compositions to treat and preventcancers and diseases related to insulin receptor substrate protein and PI3K/AKT/mTORsignal pathway.
申请人：Targeted Therapeutics, LLC
地址：Buffallo Grove IL US
国籍：US
更多信息请下载全文后查看
因篇幅问题不能全部显示，请点此查看更多更全内容